Skip to main content
SpringerLink
Log in

Nicht-kleinzelliges Lungenkarzinom

Erstmals Immuntherapie als Erstlinie bei NSCLC mit Metastasen

  • journal club
  • Published:
Pneumo News Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

1

Literatur

  1. Hegde PS, Karanikas V, Evers S: The Where, the When, and the How of Immune Monitoring for Cancer Immunotherapies in the Era of Checkpoint Inhibition. Clin Cancer Res. April 15, 2016); 22(8)

    Article  Google Scholar 

Originalie

  • Reck M, Rodríguez-Abreu D, Robinson AG et al. Pembrolizumab versus chemotherapy for PD-L1–Positive non–small-cell lung cancer. N Engl J Med 2016 Nov 10;375(19):1823–33.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Stuttgart, Deutschland

    Martin Kohlhäufl (Pneumologe)

Authors
  1. Martin Kohlhäufl
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Martin Kohlhäufl.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kohlhäufl, M. Erstmals Immuntherapie als Erstlinie bei NSCLC mit Metastasen. Pneumo News 9, 26–27 (2017). https://doi.org/10.1007/s15033-017-0660-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15033-017-0660-6

Search

Navigation